Baseline risk |
---|
(Year 1)^ | Relative risk reduction |
---|
 | 10% | 15% | 20% | 25% | 30% | 35v | 40% |
---|
15.5%
| 14.5% | 28.5% | 48.1% | 69.3% |
86.3%
|
95.7%
|
99.2%
|
- *Number of patients per treatment arm, alpha = 0.05.
- ^Year 2 risk is 27.2%.
- Bold numbers indicate statistical power range for this study.